Monoclonal antibody injections targeting CD20 antigen, administered in non-Hodgkin lymphoma and chronic lymphocytic leukemia protocols. Sourced by immunology and oncology wards in hospitals, outpatient clinics, and biotech distributors for infusion-based immunotherapeutic use.